ThetaPal ThetaPal

Manufacturing / In Vitro, In Vivo Diagnostic Substances

NEOGEN CORP

NEOG

$12.17

+$0.00 (+0.00%)

Price as of Nov 3, 2026 13:47 UTC

1.9 B

Market Cap (Small Cap)

26%

IV Rank

55.5%

Implied Volatility

Jan 06

Next Earnings

Technical Signals as of Oct 30
Mixed
4 of 7

Trend

  • Above 20-day average $12.12
  • Above 50-day average $11.98
  • Above 200-day average $10.30 · +14.8%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 85d ago

Volume

  • Below-average volume 0.5x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.95

Balanced

Implied Volatility

55.5%

0% percentile

IV vs Realized

Options rich

30d HV 48.6%

Options Heat Map

Delta-risk grid for NEOG options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

7 buys 0 sells
Date Insider Title Type Shares Value Since Trade
Oct 14, 2026 Hastings Gregory S Exercise 287 $3,444 -1.5%
Oct 14, 2026 Hastings Gregory S Tax_withholding 80 $960 -1.5%
Oct 14, 2026 Hastings Gregory S Exercise 287 $3,444 -1.5%
Oct 09, 2026 Nassif Mikheal Buy 505 $6,035 -1.1%
Oct 01, 2026 Gupta Aashima Grant 20,558 $0 -3.4%
Oct 01, 2026 Gupta Aashima Grant 9,804 $120,001 -3.4%
Oct 01, 2026 Woteki Catherine E Grant 20,558 $0 -3.4%
Oct 01, 2026 Green Ronald D Grant 20,558 $0 -3.4%
Oct 01, 2026 Pelossof Avi Grant 20,558 $0 -3.4%
Oct 01, 2026 Wainer Andrea F Grant 20,558 $0 -3.4%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Oct 07, 2026 Q1 2027 -$0.07
Oct 06, 2026 Q1 2027 -$0.07
Sep 30, 2026 Q1 2027 -$0.07 -$0.05 +30.0% Beat
Jun 30, 2026 Q4 2026 -$0.07 -$0.05 +24.6% Beat
Mar 31, 2026 Q3 2026 $0.06 $0.09 +53.3% Beat
Dec 31, 2025 Q2 2026 $0.06 $0.10 +78.3% Beat

Track NEOG with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NEOG and your entire portfolio.